MicroRNA expression in head and neck cancer associates with alcohol consumption and survival

Carcinogenesis

Volumn 30, Issue 12, 2009, Pages 2059-2063

  Avissar, Michele ^a   McClean, Michael D ^b   Kelsey, Karl T ^a,c   Marsit, Carmen J ^a  

^a BROWN UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; BIOLOGICAL MARKER; MIRN375 MICRORNA, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; LARYNX TUMOR; MALE; PHARYNX TUMOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; AGED; CASE CONTROL STUDY; DRINKING BEHAVIOR; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PAPILLOMA VIRUS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

AGED; ALCOHOL DRINKING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PAPILLOMAVIRIDAE; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 73949123790     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp277     Document Type: Article

References (57)

1. Chin,D. et al. (2006) Head and neck cancer: past, present and future. Expert Rev. Anticancer Ther., 6, 1111-1118.
2. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
3. Jemal,A. et al. (2008) Cancer statistics, 2008. CA Cancer J. Clin., 58, 71-96.
4. Ragin,C.C. et al. (2007) The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J. Dent. Res., 86, 104-114.
5. Lothaire,P. et al. (2006) Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck, 28, 256-269.
6. Thomas,G.R. et al. (2005) Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int. J. Exp. Pathol., 86, 347-363.
7. Chen,C. et al. (2008) Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 17, 2152-2162.
8. Fan,C.Y. (2004) Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications. Curr. Oncol. Rep., 6, 152-161.
9. Marsit,C.J. et al. (2009) Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis, 30, 416-422.
10. Worsham,M.J. et al. (2006) Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 132, 668-677.
11. Schickel,R. et al. (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene, 27, 5959-5974.
12. Ambros,V. (2004) The functions of animal microRNAs. Nature, 431, 350-355.
13. Cullen,B.R. (2004) Transcription and processing of human microRNA precursors. Mol. Cell, 16, 861-865.
14. Calin,G.A. et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 353, 1793-1801.
15. Yan,L.X. et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 14, 2348-2360.
16. Schetter,A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
17. Chen,Y. et al. (2007) Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res., 67, 976-983.
18. Avissar,M. et al. (2009) MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin. Cancer Res., 15, 2850-2855.
19. Chang,S.S. et al. (2008) MicroRNA alterations in head and neck squamous cell carcinoma. Int. J. Cancer, 123, 2791-2797.
20. Childs,G. et al. (2009) Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am. J. Pathol., 174, 736-745.
21. Ramdas,L. et al. (2009) miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck, 31, 642-654.
22. Chaudhry,M.A. (2009) Real-time PCR analysis of micro-RNA expression in ionizing radiation-treated cells. Cancer Biother. Radiopharm., 24, 49-56.
23. Marsit,C.J. et al. (2006) Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int. J. Cancer, 119, 1761-1766.
24. Zhang,B. et al. (2009) RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ. Health Perspect., 117, 231-240.
25. Peters,E.S. et al. (2005) The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol. Biomarkers Prev., 14, 476-482.
26. Furniss,C.S. et al. (2008) Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol. Biomarkers Prev., 17, 966-971.
27. Furniss,C.S. et al. (2007) Human papillomavirus 16 and head and neck squamous cell carcinoma. Int. J. Cancer, 120, 2386-2392.
28. Slaby,O. et al. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology, 72, 397-402.
29. Yanaihara,N. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198.
30. Yu,S.L. et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48-57.
31. Liu,W.H. et al. (2009) MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology, 136, 683-693.
32. Guo,J. et al. (2009) Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol., 24, 652-657.
33. Motoyama,K. et al. (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int. J. Oncol., 34, 1069-1075.
34. Nam,E.J. et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res., 14, 2690-2695.
35. Park,J.K. et al. (2009) Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas, 38, e190-e199.
36. Zhang,C. et al. (2009) Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int. J. Oncol., 34, 1653-1660.
37. Krichevsky,A.M. et al. (2009) miR-21: a small multi-faceted RNA. J. Cell. Mol. Med., 13, 39-53.
38. Selcuklu,S.D. et al. (2009) miR-21 as a key regulator of oncogenic processes. Biochem. Soc. Trans., 37, 918-925.
39. Poy,M.N. et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 432, 226-230.
40. Poy,M.N. et al. (2009) miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc. Natl Acad. Sci. USA, 106, 5813-5818.
41. Mathe,E.A. et al. (2009) MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res., 15, 6192-6200.
42. Bloomston,M. et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 297, 1901-1908.
43. El Ouaamari,A. et al. (2008) miR-375 targets 3#-phosphoinositidedependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes, 57, 2708-2717.
44. Pietrzykowski,A.Z. et al. (2008) Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron, 59, 274-287.
45. Wang,L.L. et al. (2009) Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum. Reprod., 24, 562-579.
46. Ladeiro,Y. et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 47, 1955-1963.
47. Seitz,H.K. et al. (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer, 7, 599-612.
48. Homann,N. et al. (2000) Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis, 21, 663-668.
49. Muto,M. et al. (2000) Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: implications for carcinogenesis in upper aerodigestive tract. Int. J. Cancer, 88, 342-350.
50. Hamid,A. et al. (2009) New perspectives on folate transport in relation to alcoholism-induced folate malabsorption-association with epigenome stability and cancer development. FEBS J., 276, 2175-2191.
51. Iorio,M.V. et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res., 67, 8699-8707.
52. Lu,J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
53. Markou,A. et al. (2008) Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin. Chem., 54, 1696-1704.
54. Frankel,L.B. et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 283, 1026-1033.
55. Li,T. et al. (2009) MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem. Biophys. Res. Commun., 383, 280-285.
56. Meng,F. et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
57. Pedrero,J.M. et al. (2005) Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int. J. Cancer, 114, 242-248.